Ultrasound Guided Ureteroscopy and Ureteric Stones

Ureteric Stone Clinical Trial

Official title:

Ultrasound Guided Ureteroscopy for the Treatment of Lower Third Ureteric Stones in Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03404986
• Other study ID #: USUUS
• Status: Completed
• Phase: N/A
• Start date: April 1, 2018
• Est. completion date: April 1, 2020

Study information

• Verified date: December 2022
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The prevalence of urolithiasis is steadily increasing with an estimation of 1 out of 11 people in the United States. The prevalence of calculi in Afro-Asian region including Arab Republic of Egypt ranges from 4% to 20%. Ureteroscopy is one of the first line treatments for definitive management of ureteric stones. Conventional ureteroscopy relies on intraoperative fluoroscopy for visualization and guidance, exposing the patient, surgeon and operating room staff to ionizing radiation. To minimize the hazards of ionizing radiation there has been a trend toward radiation free alternative imaging modalities . Ultrasound provides an excellent alternative for upper urinary tract imaging because it is radiation free, rapid, portable and allows excellent visualization of the renal pelvis and calyces. There is increasing awareness and concern about the clinical use of ionizing radiation and the need to decrease exposure of patients and medical professionals. Ultrasound guided ureteroscopy in pregnant females and children- in whom fluoroscopy is to be minimized or avoided when possible - has been reported.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: April 1, 2020
• Est. primary completion date: April 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Patients with single symptomatic lower third ureteric radio-opaque stones indicated for endoscopic treatment.

2. Age group 18 years old or above.

3. Stone size 15 mm or less.

Exclusion Criteria:

1. Patients with bilateral ureteric stones

2. Ureteric congenital anomalies e.g. double ureter and ectopic ureter.

3. Previously failed ureteroscopy or previous ureteroneocystostomy.

Related Conditions & MeSH terms

• Ureteral Calculi
• Ureteric Stone
• Ureterolithiasis

Intervention

Procedure:
• ureteroscopy
The patients will be subjected to rigid ureteroscopy

Radiation:
• Ultrasonography
The patients will be subjected to Ultrasonography

Locations

Country	Name	City	State
Egypt	Women Health Hospital - Assiut university	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients treated effectively by the two methods		1 hour